Internal Medicine, Gastroenterology · Louisville, KY
NPI
1659355774
Since 2005
Specialty
Internal Medicine, Gastroenterology
Code 207RG0100X
Group practices
1
Medicare group memberships
Hospitals
0
Hospital affiliations
1169 Eastern Pkwy, G58
Louisville, KY, 40217
Phone (502) 452-9567
Groups this clinician bills Medicare through
Medicare paid, 2024
$206K
13,973 services
Medicare patients, 2024
316
Average age 74
Drug cost, 2024
$1.3M
2,172 prescriptions
Company payments, 2024
$2,731
From 27 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Paul E Brown was code J1745 (injection, infliximab, excludes biosimilar, 10 mg), 1,450 times for 12 patients. In total Paul E Brown billed 13,973 services in 25 codes, and Medicare paid $206K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2022-08-18.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| J1745 Injection, infliximab, excludes biosimilar, 10 mg | Office | 1,450 | 12 | $24.60 | $36K |
| 99214 Office E&M - Established | Office | 114 | 93 | $84.33 | $9,613 |
| 99426 Chronic, Principal, and Transitional Care Management | Office | 60 | 20 | $41.70 | $2,502 |
| 99222 Hospital E&M - Initial | Facility | 59 | 57 | $95.81 | $5,653 |
| 99204 Office E&M - New | Office | 54 | 54 | $103.87 | $5,609 |
| 99490 Chronic, Principal, and Transitional Care Management | Office | 43 | 14 | $46.27 | $1,989 |
| 99213 Office E&M - Established | Office | 37 | 36 | $57.95 | $2,144 |
| 99223 Hospital E&M - Initial | Facility | 35 | 35 | $125.30 | $4,386 |
| 96413 Chemotherapy Administration | Office | 33 | 15 | $89.28 | $2,946 |
| 96415 Chemotherapy Administration | Office | 29 | 12 | $19.50 | $566 |
| 96365 Intravenous Infusion, Hydration | Office | 25 | 13 | $43.62 | $1,091 |
| 43239 Upper GI Endoscopy | Facility | 19 | 19 | $95.82 | $1,821 |
By year: 2022 $374K for 12,940 services; 2023 $204K for 12,222 services; 2024 $206K for 13,973 services.
Medicare prescription drug claims, 2024
In 2024, the drug Paul E Brown prescribed most often to Medicare patients was Pantoprazole Sodium, with 760 prescriptions and refills. In total Paul E Brown wrote 2,172 Medicare prescriptions that cost $1.3M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Pantoprazole Sodium Generic | 760 | 1,669 | 197 | $8,627 |
| Omeprazole Generic | 261 | 643 | 76 | $3,755 |
| Dicyclomine Hcl Generic | 200 | 350 | 67 | $3,042 |
| Esomeprazole Magnesium Generic | 149 | 368 | 39 | $5,121 |
| Linzess Linaclotide | 90 | 124 | 25 | $66K |
| Famotidine Generic | 84 | 214 | 26 | $867 |
| Lansoprazole Generic | 49 | 99 | 11 | $877 |
| Ondansetron Hcl Generic | 45 | 45 | Under 11 | $548 |
| Mesalamine Dr Mesalamine | 39 | 69 | Under 11 | $29K |
| Sucralfate Generic | 37 | 57 | 11 | $5,954 |
| Mesalamine Generic | 34 | 74 | Under 11 | $26K |
| Ursodiol Generic | 33 | 39 | Under 11 | $2,927 |
| Mesalamine Er Mesalamine | 32 | 71 | Under 11 | $9,039 |
| Promethazine Hcl Generic | 28 | 28 | Under 11 | $53.45 |
| Stelara Ustekinumab | 28 | 50 | Under 11 | $763K |
Brand drugs: 240 claims; generic drugs: 1,932 claims.
Money and other things of value reported by the companies
In 2024, drug and medical device companies paid Paul E Brown $2,731 ($2,731 in general payments such as food, travel and fees) from 27 companies. The largest payer was Abbvie Inc. with $538.
| Company | Payments | Amount |
|---|---|---|
| Abbvie Inc. ABBV | 31 | $538 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC BHC | 23 | $370 |
| Janssen Biotech, Inc. JNJ | 18 | $242 |
| Takeda Pharmaceuticals U.S.A., Inc. TAK | 13 | $214 |
| Ardelyx, Inc. ARDX | 8 | $145 |
| Pfizer Inc. PFE | 8 | $135 |
| Regeneron Healthcare Solutions, Inc. REGN | 5 | $129 |
| Merck Sharp & Dohme LLC MRK | 5 | $106 |
| QOL Medical, LLC | 3 | $85.95 |
| Aimmune Therapeutics, Inc. | 3 | $80.51 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.